Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
Open Access
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-15
- https://doi.org/10.1038/s41598-021-83872-z
Abstract
Tau pathology in Alzheimer’s disease (AD) spreads in a predictable pattern that corresponds with disease symptoms and severity. At post-mortem there are cortical regions that range from mildly to severely affected by tau pathology and neuronal loss. A comparison of the molecular signatures of these differentially affected areas within cases and between cases and controls may allow the temporal modelling of disease progression. Here we used RNA sequencing to explore differential gene expression in the mildly affected primary visual cortex and moderately affected precuneus of ten age-, gender- and RNA quality-matched post-mortem brains from AD patients and healthy controls. The two regions in AD cases had similar transcriptomic signatures but there were broader abnormalities in the precuneus consistent with the greater tau load. Both regions were characterised by upregulation of immune-related genes such as those encoding triggering receptor expressed on myeloid cells 2 and membrane spanning 4-domains A6A and milder changes in insulin/IGF1 signalling. The precuneus in AD was also characterised by changes in vesicle secretion and downregulation of the interneuronal subtype marker, somatostatin. The ‘early’ AD transcriptome is characterised by perturbations in synaptic vesicle secretion on a background of neuroimmune dysfunction. In particular, the synaptic deficits that characterise AD may begin with the somatostatin division of inhibitory neurotransmission.Keywords
This publication has 68 references indexed in Scilit:
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease riskNature Genetics, 2019
- Neuronal activity enhances tau propagation and tau pathology in vivoNature Neuroscience, 2016
- Mapping RNA‐seq Reads with STARCurrent Protocols in Bioinformatics, 2015
- The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer’s disease patientsMolecular Biology Reports, 2014
- U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s diseaseProceedings of the National Academy of Sciences of the United States of America, 2013
- Relation of neuropathology with cognitive decline among older persons without dementiaFrontiers in Aging Neuroscience, 2013
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Somatostatin replacement therapy for alzheimer dementiaAnnals of Neurology, 1991
- Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patientsNature, 1985
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980